Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
ABclonal logo

ABclonal

Recent Finacing

Series C

Recent Raise

$91.9M

ABclonal Technology is a US-based biotech company supplying custom antibodies, reagents, enzymes, and related services to support biological and molecular research workflows.

Founded 2011
Hubei, China
501-1K
abclonal.com

Highlights

Focus Areas

Biometrics
Biopharma
Biotechnology

Recent Investors

LYFE Capital logo

Financials

$91.9M

Total Raised

1

Funding round

1

Investor


Team

Upgrade to view the team

See the team members at ABclonal.